Paul Brindley, PhD, has received more than $1.7 million from the National Cancer Institute at the National Institutes of Health to investigate the cellular and molecular links between liver fluke infection and bile duct cancer.
The GW School of Medicine and Health Sciences is one of 12 top medical research centers to collaborate with the Scleroderma Research Foundation to launch CONQUER: the first-ever national, longitudinal patient registry for those suffering from...
The GW Cancer Center is pleased to announce that Katherine Chiappinelli, PhD, was awarded a prestigious grant from The G. Harold and Leila Y. Mathers Foundation.
Transgender individuals may be at higher risk for heart disease, according to a review article published by Michael S. Irwig, MD, associate professor of medicine, in Reviews in Endocrine and Metabolic Disorders.
Robert H. Miller, PhD, a neuroscientist, researcher, and administrator in the GW School of Medicine and Health Sciences, has been named the university’s new vice president for research.
The GW School of Medicine and Health Sciences renamed the Department of Anatomy and Regenerative Biology to the Department of Anatomy and Cell Biology.
Adam Friedman, MD, professor of dermatology at the GW School of Medicine and Health Sciences, and his team investigated the use of nanotechnology to improve efinaconazole treatment and make it more cost effective.
A recent clinical trial at GW showed no significant support for tamsulosin use for kidney stone passage.
Research published in Cancer Cell by George Washington University (GW) Cancer Center researcher Alexandros Tzatsos, MD, PhD, found an important connection between the KDM6A gene and the most aggressive form of pancreatic cancer.
A team of researchers at the GW School of Medicine and Health Sciences compared the toxicological impact of cryosurgery with an FDA-approved topical 40 percent hydrogen peroxide solution (A-101) for the treatment of seborrheic keratosis, in human...